Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Annette Gylling"'
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1202 (2023)
Genital warts (GWs) caused by the human papilloma virus (HPV) are a significant health problem due to high prevalence and rate of recurrence. Bivalent vaccine has been used since the start of the national vaccination program in 2013, making it feasib
Externí odkaz:
https://doaj.org/article/a2cdb1724e8b405da03b2530fc193e7c
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1202
Genital warts (GWs) caused by the human papilloma virus (HPV) are a significant health problem due to high prevalence and rate of recurrence. Bivalent vaccine has been used since the start of the national vaccination program in 2013, making it feasib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::5f93adb41607d39498104a427a0d9a19
Autor:
Maria, Hemming-Harlo, Annette, Gylling, Fredrik, Herse, Ira, Haavisto, Mikko, Nuutinen, Michael, Pasternack, M Nabi, Kanibir, Susanne, Hartwig, Cristina, Carias
Publikováno v:
Vaccine. 40:3942-3947
Rotavirus (RV) vaccination was included in the Finnish National immunization Program (NIP) in 2009. RotaTeq (RV5) has been used exclusively with a national average vaccination coverage rate (VCR) of 90%. While previous studies have demonstrated that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c52dc2d854c78256ade2f2faf89a13
https://doi.org/10.1016/j.vaccine.2022.04.104
https://doi.org/10.1016/j.vaccine.2022.04.104
Autor:
Karl Heinimann, Mihaela Zavolan, Luigi Terracciano, Päivi Peltomäki, Giancarlo Marra, Valentina Mele, Hans Joerg Altermatt, Francesca Trapani, Friedel Wenzel, Annette Gylling, Michal B. Kovac, Salvatore Piscuoglio, Shivendra Kishore
PDF file - 300K, Supplementary Figure 1: Immunohistochemical profiling of DNA mismatch repair proteins in the extra-osseous Ewing Sarcoma. Supplementary Figure 2: Fluorescence in situ hybridization (FISH) analysis of the MHS6-related extra-osseous Ew
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c785ecf97c843deecc3dae36eaf3b55
https://doi.org/10.1158/0008-5472.22400313.v1
https://doi.org/10.1158/0008-5472.22400313.v1
Autor:
Annette Gylling, Taina T. Nieminen, Samuli Eldfors, Anna Lepistö, Jukka-Pekka Mecklin, Alisa Olkinuora, Päivi Peltomäki, Henrikki Almusa
Publikováno v:
Cancers
Volume 12
Issue 7
Cancers, Vol 12, Iss 1853, p 1853 (2020)
Volume 12
Issue 7
Cancers, Vol 12, Iss 1853, p 1853 (2020)
Some 10&ndash
50% of Lynch-suspected cases with abnormal immunohistochemical (IHC) staining remain without any identifiable germline mutation of DNA mismatch repair (MMR) genes. MMR proteins form heterodimeric complexes, giving rise to distinct
50% of Lynch-suspected cases with abnormal immunohistochemical (IHC) staining remain without any identifiable germline mutation of DNA mismatch repair (MMR) genes. MMR proteins form heterodimeric complexes, giving rise to distinct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e6016305c84c5bdcbd925d95e0f4e6d
Autor:
Taina T. Nieminen, Ari Ristimäki, Annette Gylling, Anna Lepistö, Päivi Peltomäki, Laura Renkonen-Sinisalo, Laura Koskenvuo
Publikováno v:
Journal of Surgical Oncology. 113:209-212
Background The prevalence of desmoid tumors among patients with familial adenomatous polyposis (FAP) is at least 10%, and the prevalence of FAP among desmoid patients varies between 7.5–16%. Methods Data included 106 desmoid patients identified fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e3b8451a8ceb431b4f886254e97a24f
https://doi.org/10.1002/jso.24117
https://doi.org/10.1002/jso.24117
Autor:
Annette Gylling, Juha-Pekka Pursiheimo, Attila Gyenesei, Walter Hernán Pavicic, Asta Laiho, Heikki Järvinen, Päivi Peltomäki, Taina T. Nieminen
Publikováno v:
Genes, Chromosomes and Cancer. 53:857-864
Fil: Pavicic, Walter Hernan. Consejo Nacional de Investigaciones Cientificas y Tecnicas. Centro Cientifico Tecnologico Conicet - La Plata. Instituto Multidisciplinario de Biologia Celular. Provincia de Buenos Aires. Gobernacion. Comision de Investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e537a7ebc7fc015d01b2e5cff1bd9f09
https://doi.org/10.1002/gcc.22197
https://doi.org/10.1002/gcc.22197
Autor:
Michal Kovac, Päivi Peltomäki, Giancarlo Marra, Friedel Wenzel, Luigi Terracciano, Annette Gylling, Salvatore Piscuoglio, Hans Joerg Altermatt, Mihaela Zavolan, Francesca Trapani, Karl Heinimann, Valentina Mele, Shivendra Kishore
Publikováno v:
Cancer Research
The genome-wide accumulation of DNA replication errors known as microsatellite instability (MSI) is the hallmark lesion of DNA mismatch repair (MMR)–deficient cancers. Although testing for MSI is widely used to guide clinical management, the contri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc544989e815b10d4476ccecd8771a0a
https://doi.org/10.1158/0008-5472.can-13-2100
https://doi.org/10.1158/0008-5472.can-13-2100
Autor:
Laura Lahtinen, Annette Gylling, Jonas Kantonen, Mira Heinonen, Ari Ristimäki, Jukka-Pekka Mecklin, Arto Orpana, Alexandra Thiel, Soili Kytölä, Päivi Peltomäki, Mari K. Korhonen
Publikováno v:
Virchows Archiv
The aim of the study was to detect mutations of BRAF oncogene in colorectal cancer and to use this information to identify Lynch syndrome patients. Consecutive cases of primary colorectal cancer (n = 137) were analyzed for MLH1 protein expression usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdb8e7ac314220c6edb3510070e34978
https://doi.org/10.1007/s00428-013-1470-9
https://doi.org/10.1007/s00428-013-1470-9
Autor:
Matti Juhola, Matti Säily, Heikki Järvinen, Annette Gylling, Markku Aarnio, Jukka-Pekka Mecklin, Päivi Peltomäki
Publikováno v:
Familial Cancer
Increased risk for urological tumors has been observed in mutation carriers with Lynch syndrome (LS). In this study, we evaluated the clinical features of uroepithelial (bladder and ureter) and kidney cancers in 974 Finnish mutation carriers. Altoget
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71194c1041a5d091a75872e3afbc0224
https://doi.org/10.1007/s10689-012-9526-6
https://doi.org/10.1007/s10689-012-9526-6